Beractant, also known by the trade name of Survanta, is a modified bovine
pulmonary surfactant containing bovine lung extract to which synthetic DPPC, ...
Learn about SURVANTA® (beractant) dosing, administration, safety and efficacy
for prevention and treatment of respiratory distress syndrome (RDS)
Physician reviewed beractant patient information - includes beractant description,
dosage and directions.
SURVANTA ® (beractant) Intratracheal Suspension is a sterile, non-pyrogenic
pulmonary surfactant intended for intratracheal use only. It is a natural bovine ...
Reduces incidence and mortality due to respiratory distress syndrome and air
leak complications. 100mg of phospholipids/kg birth weight (4mL/kg) per dose.
Drug information on Survanta Intratracheal (beractant), includes drug pictures,
side effects, drug interactions, directions for use, symptoms of overdose, and
Consumer Medicine Information (CMI) about Survanta (beractant) intended for
persons living in Australia.
Nov 6, 2015 ... 1. Name of the medicinal product. Survanta 25mg/ml suspension. 2. Qualitative
and quantitative composition. Each ml contains beractant ...
SURVANTA® (beractant) Intratracheal Suspension is a sterile, non-pyrogenic
pulmonary surfactant intended for intratracheal use only. It is a natural bovine
Mar 18, 2015 ... Beractant is a lung surface acting agent, or "surfactant." It helps the lungs function
normally. Beractant is similar to the natural fluid in the lungs ...